Sysmex America Awarded Laboratory Diagnostic Products Distribution Contract with Vizient
  Release Date:  July 01, 2020  
Sysmex Media Relations 
Lincolnshire, IL – July 1, 2020 – Sysmex America, Inc., a leading diagnostic solutions company for optimal clinical laboratory performance, announced its hematology testing technology and accompanying information system has been awarded a contract with Vizient, Inc., effective July 1, 2020.

This new laboratory diagnostic products contract will offer Vizient members a full range of hematology analyzers, reagents and service featuring superior technology, system flexibility and workflow efficiency. The hematology products available include instruments from the lower volume XN-L™ series to the fully automated scalable XN-9100™ system.

“With over 50 years of hematology expertise and a vast portfolio of quality solutions, we are happy to share our expertise and respond to Vizient member demand for advanced diagnostic instruments at enhanced savings that help them improve clinical laboratory performance,” said Andy Hay, chief operating officer of Sysmex America. 

Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers. To learn more about Sysmex America products, visit

About Sysmex America
Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit please visit


© Copyright Sysmex